← Eichor
Study identifier: NCT07337434 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

To Check Comparison of Apremilast and Methotrexate Efficacy in Patients With Moderate to Severe Plaque Psoriasis Presented to Tertiary Care Hospital

Condition: Chronic Plaque Psoriasis  ·  Sponsor: Syeda Sana Zaman

PhaseEARLY_Phase 1
Planned participants106
Who can joinAll sexes, 18 Years to 60 Years
Healthy volunteersYes

About this study

This study aims to compare efficacy of methotrexate vs apremilast in the management of chronic plaque psoriasis.Given the high prevalence of psoriasis in Pakistan and the significant psychological impact on patients, particularly in Peshawer,this study will provide valuable insights into optimal treatment strategies.

This description comes directly from the study's public registry record.

Talk to the study team

Filza Ajmal, FCPS part 2  ·  +923008179226  ·  binteajmal1996@gmail.com

Ghafoor Ullah  ·  923335939818  ·  dr_ghafoorullah@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (1)

MTI-HMC PeshawarPeshawar, Khyber Pukhtunkhwa, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07337434